Stuart Rich
Chief Medical Officer at Tenax Therapeutics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 2 years
- Director since
- 2024
2 years of board service in total across 1 board, counting each seat separately. Longest: Tenax Therapeutics Inc., 2 years.
Tenax Therapeutics Inc.
Director · Chief Medical Officer
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 9, 2025 | Tenax Therapeutics Inc. | Open-market purchase | +2,500 | $10.22 | $25,550 |
| Dec 8, 2025 | Tenax Therapeutics Inc. | Open-market purchase | +2,500 | $10.10 | $25,250 |
| Dec 4, 2025 | Tenax Therapeutics Inc. | Open-market purchase | +2,500 | $9.20 | $23,000 |
| Dec 3, 2025 | Tenax Therapeutics Inc. | Open-market purchase | +1,500 | $9.08 | $13,620 |
| Dec 2, 2025 | Tenax Therapeutics Inc. | Open-market purchase | +1,000 | $9.01 | $9,010 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.